Texas HB1304 mandates labeling for products containing or derived from aborted human fetal tissue.
Texas HB1304 amends the Health and Safety Code to require clear and conspicuous labeling for products containing or derived from aborted human fetal tissue. This includes food, medical, cosmetic, and other products. The bill defines "human fetal tissue" as tissue, cells, or organs obtained from an aborted unborn child. The executive commissioner of the Health and Human Services Commission must adopt the form and content of the required labels by December 1, 2025. These labeling requirements apply to products sold, dispensed, or administered on or after January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.